nodes	percent_of_prediction	percent_of_DWPC	metapath
Sitaxentan—CYP2C19—epilepsy syndrome	0.218	1	CbGaD
Sitaxentan—CYP2C19—Oxcarbazepine—epilepsy syndrome	0.0249	0.0527	CbGbCtD
Sitaxentan—CYP2C19—Felbamate—epilepsy syndrome	0.0232	0.0489	CbGbCtD
Sitaxentan—CYP2C19—Trimethadione—epilepsy syndrome	0.0232	0.0489	CbGbCtD
Sitaxentan—CYP2C19—Fosphenytoin—epilepsy syndrome	0.0218	0.046	CbGbCtD
Sitaxentan—CYP2C9—Trimethadione—epilepsy syndrome	0.0193	0.0407	CbGbCtD
Sitaxentan—CYP2C19—Clobazam—epilepsy syndrome	0.0189	0.0399	CbGbCtD
Sitaxentan—CYP2C9—Fosphenytoin—epilepsy syndrome	0.0181	0.0383	CbGbCtD
Sitaxentan—CYP2C19—Carbamazepine—epilepsy syndrome	0.0157	0.0331	CbGbCtD
Sitaxentan—CYP2C19—Primidone—epilepsy syndrome	0.0146	0.0309	CbGbCtD
Sitaxentan—CYP2C19—Phenytoin—epilepsy syndrome	0.014	0.0297	CbGbCtD
Sitaxentan—CYP2C19—Propofol—epilepsy syndrome	0.0131	0.0277	CbGbCtD
Sitaxentan—CYP2C9—Carbamazepine—epilepsy syndrome	0.013	0.0275	CbGbCtD
Sitaxentan—CYP2C19—Phenobarbital—epilepsy syndrome	0.0125	0.0264	CbGbCtD
Sitaxentan—CYP2C9—Primidone—epilepsy syndrome	0.0122	0.0257	CbGbCtD
Sitaxentan—CYP3A4—Oxcarbazepine—epilepsy syndrome	0.0121	0.0255	CbGbCtD
Sitaxentan—CYP2C19—Diazepam—epilepsy syndrome	0.0119	0.0251	CbGbCtD
Sitaxentan—CYP2C9—Phenytoin—epilepsy syndrome	0.0117	0.0247	CbGbCtD
Sitaxentan—CYP2C19—Zonisamide—epilepsy syndrome	0.0116	0.0245	CbGbCtD
Sitaxentan—CYP3A4—Felbamate—epilepsy syndrome	0.0112	0.0237	CbGbCtD
Sitaxentan—CYP3A4—Trimethadione—epilepsy syndrome	0.0112	0.0237	CbGbCtD
Sitaxentan—CYP2C9—Propofol—epilepsy syndrome	0.0109	0.023	CbGbCtD
Sitaxentan—CYP3A4—Fosphenytoin—epilepsy syndrome	0.0105	0.0222	CbGbCtD
Sitaxentan—CYP2C9—Phenobarbital—epilepsy syndrome	0.0104	0.022	CbGbCtD
Sitaxentan—CYP2C9—Diazepam—epilepsy syndrome	0.00987	0.0208	CbGbCtD
Sitaxentan—CYP3A4—Clonazepam—epilepsy syndrome	0.00953	0.0201	CbGbCtD
Sitaxentan—CYP2C19—Valproic Acid—epilepsy syndrome	0.00935	0.0198	CbGbCtD
Sitaxentan—CYP3A4—Clobazam—epilepsy syndrome	0.00913	0.0193	CbGbCtD
Sitaxentan—CYP2C19—Topiramate—epilepsy syndrome	0.00844	0.0178	CbGbCtD
Sitaxentan—CYP2C9—Valproic Acid—epilepsy syndrome	0.00778	0.0164	CbGbCtD
Sitaxentan—CYP3A4—Rufinamide—epilepsy syndrome	0.00777	0.0164	CbGbCtD
Sitaxentan—CYP3A4—Carbamazepine—epilepsy syndrome	0.00757	0.016	CbGbCtD
Sitaxentan—CYP3A4—Primidone—epilepsy syndrome	0.00707	0.0149	CbGbCtD
Sitaxentan—CYP3A4—Phenytoin—epilepsy syndrome	0.00679	0.0143	CbGbCtD
Sitaxentan—CYP3A4—Propofol—epilepsy syndrome	0.00633	0.0134	CbGbCtD
Sitaxentan—CYP3A4—Phenobarbital—epilepsy syndrome	0.00605	0.0128	CbGbCtD
Sitaxentan—CYP3A4—Acetazolamide—epilepsy syndrome	0.00605	0.0128	CbGbCtD
Sitaxentan—CYP3A4—Midazolam—epilepsy syndrome	0.00597	0.0126	CbGbCtD
Sitaxentan—CYP3A4—Diazepam—epilepsy syndrome	0.00574	0.0121	CbGbCtD
Sitaxentan—CYP3A4—Zonisamide—epilepsy syndrome	0.0056	0.0118	CbGbCtD
Sitaxentan—CYP3A4—Valproic Acid—epilepsy syndrome	0.00452	0.00955	CbGbCtD
Sitaxentan—CYP3A4—Topiramate—epilepsy syndrome	0.00408	0.00862	CbGbCtD
Sitaxentan—Hypersensitivity—Clonazepam—epilepsy syndrome	3.23e-05	0.000154	CcSEcCtD
Sitaxentan—Dizziness—Vigabatrin—epilepsy syndrome	3.22e-05	0.000154	CcSEcCtD
Sitaxentan—Confusional state—Valproic Acid—epilepsy syndrome	3.22e-05	0.000153	CcSEcCtD
Sitaxentan—Hypersensitivity—Phenytoin—epilepsy syndrome	3.21e-05	0.000153	CcSEcCtD
Sitaxentan—Oedema—Valproic Acid—epilepsy syndrome	3.19e-05	0.000152	CcSEcCtD
Sitaxentan—Urticaria—Lamotrigine—epilepsy syndrome	3.19e-05	0.000152	CcSEcCtD
Sitaxentan—Hypersensitivity—Oxcarbazepine—epilepsy syndrome	3.19e-05	0.000152	CcSEcCtD
Sitaxentan—Bradycardia—Topiramate—epilepsy syndrome	3.19e-05	0.000152	CcSEcCtD
Sitaxentan—Malaise—Pregabalin—epilepsy syndrome	3.19e-05	0.000152	CcSEcCtD
Sitaxentan—Nausea—Propofol—epilepsy syndrome	3.19e-05	0.000152	CcSEcCtD
Sitaxentan—Tension—Gabapentin—epilepsy syndrome	3.18e-05	0.000152	CcSEcCtD
Sitaxentan—Vomiting—Fosphenytoin—epilepsy syndrome	3.18e-05	0.000151	CcSEcCtD
Sitaxentan—Diarrhoea—Felbamate—epilepsy syndrome	3.18e-05	0.000151	CcSEcCtD
Sitaxentan—Vertigo—Pregabalin—epilepsy syndrome	3.18e-05	0.000151	CcSEcCtD
Sitaxentan—Body temperature increased—Lamotrigine—epilepsy syndrome	3.18e-05	0.000151	CcSEcCtD
Sitaxentan—Dizziness—Diazepam—epilepsy syndrome	3.17e-05	0.000151	CcSEcCtD
Sitaxentan—Infection—Valproic Acid—epilepsy syndrome	3.17e-05	0.000151	CcSEcCtD
Sitaxentan—Leukopenia—Pregabalin—epilepsy syndrome	3.16e-05	0.000151	CcSEcCtD
Sitaxentan—Rash—Fosphenytoin—epilepsy syndrome	3.15e-05	0.00015	CcSEcCtD
Sitaxentan—Dermatitis—Fosphenytoin—epilepsy syndrome	3.15e-05	0.00015	CcSEcCtD
Sitaxentan—Haemoglobin—Topiramate—epilepsy syndrome	3.15e-05	0.00015	CcSEcCtD
Sitaxentan—Nervousness—Gabapentin—epilepsy syndrome	3.15e-05	0.00015	CcSEcCtD
Sitaxentan—Asthenia—Clonazepam—epilepsy syndrome	3.14e-05	0.00015	CcSEcCtD
Sitaxentan—Rhinitis—Topiramate—epilepsy syndrome	3.14e-05	0.00015	CcSEcCtD
Sitaxentan—Headache—Fosphenytoin—epilepsy syndrome	3.13e-05	0.000149	CcSEcCtD
Sitaxentan—Haemorrhage—Topiramate—epilepsy syndrome	3.13e-05	0.000149	CcSEcCtD
Sitaxentan—Hepatitis—Topiramate—epilepsy syndrome	3.13e-05	0.000149	CcSEcCtD
Sitaxentan—Nervous system disorder—Valproic Acid—epilepsy syndrome	3.13e-05	0.000149	CcSEcCtD
Sitaxentan—Thrombocytopenia—Valproic Acid—epilepsy syndrome	3.13e-05	0.000149	CcSEcCtD
Sitaxentan—Asthenia—Phenytoin—epilepsy syndrome	3.12e-05	0.000149	CcSEcCtD
Sitaxentan—Nausea—Midazolam—epilepsy syndrome	3.12e-05	0.000148	CcSEcCtD
Sitaxentan—Muscle spasms—Gabapentin—epilepsy syndrome	3.12e-05	0.000148	CcSEcCtD
Sitaxentan—Tachycardia—Valproic Acid—epilepsy syndrome	3.12e-05	0.000148	CcSEcCtD
Sitaxentan—Diarrhoea—Zonisamide—epilepsy syndrome	3.11e-05	0.000148	CcSEcCtD
Sitaxentan—Asthenia—Oxcarbazepine—epilepsy syndrome	3.11e-05	0.000148	CcSEcCtD
Sitaxentan—Vomiting—Vigabatrin—epilepsy syndrome	3.1e-05	0.000148	CcSEcCtD
Sitaxentan—Skin disorder—Valproic Acid—epilepsy syndrome	3.1e-05	0.000148	CcSEcCtD
Sitaxentan—Urinary tract disorder—Topiramate—epilepsy syndrome	3.09e-05	0.000147	CcSEcCtD
Sitaxentan—Oedema peripheral—Topiramate—epilepsy syndrome	3.09e-05	0.000147	CcSEcCtD
Sitaxentan—Nausea—Levetiracetam—epilepsy syndrome	3.08e-05	0.000147	CcSEcCtD
Sitaxentan—Rash—Vigabatrin—epilepsy syndrome	3.07e-05	0.000146	CcSEcCtD
Sitaxentan—Dizziness—Felbamate—epilepsy syndrome	3.07e-05	0.000146	CcSEcCtD
Sitaxentan—Dermatitis—Vigabatrin—epilepsy syndrome	3.07e-05	0.000146	CcSEcCtD
Sitaxentan—Urethral disorder—Topiramate—epilepsy syndrome	3.07e-05	0.000146	CcSEcCtD
Sitaxentan—Hypersensitivity—Carbamazepine—epilepsy syndrome	3.06e-05	0.000146	CcSEcCtD
Sitaxentan—Headache—Vigabatrin—epilepsy syndrome	3.05e-05	0.000145	CcSEcCtD
Sitaxentan—Vomiting—Diazepam—epilepsy syndrome	3.05e-05	0.000145	CcSEcCtD
Sitaxentan—Anorexia—Valproic Acid—epilepsy syndrome	3.04e-05	0.000145	CcSEcCtD
Sitaxentan—Tremor—Gabapentin—epilepsy syndrome	3.04e-05	0.000145	CcSEcCtD
Sitaxentan—Rash—Diazepam—epilepsy syndrome	3.03e-05	0.000144	CcSEcCtD
Sitaxentan—Dermatitis—Diazepam—epilepsy syndrome	3.02e-05	0.000144	CcSEcCtD
Sitaxentan—Visual impairment—Topiramate—epilepsy syndrome	3.02e-05	0.000144	CcSEcCtD
Sitaxentan—Chest pain—Pregabalin—epilepsy syndrome	3.01e-05	0.000143	CcSEcCtD
Sitaxentan—Ill-defined disorder—Gabapentin—epilepsy syndrome	3.01e-05	0.000143	CcSEcCtD
Sitaxentan—Dizziness—Zonisamide—epilepsy syndrome	3.01e-05	0.000143	CcSEcCtD
Sitaxentan—Headache—Diazepam—epilepsy syndrome	3.01e-05	0.000143	CcSEcCtD
Sitaxentan—Diarrhoea—Clonazepam—epilepsy syndrome	3e-05	0.000143	CcSEcCtD
Sitaxentan—Anaemia—Gabapentin—epilepsy syndrome	3e-05	0.000143	CcSEcCtD
Sitaxentan—Unspecified disorder of skin and subcutaneous tissue—Pregabalin—epilepsy syndrome	2.99e-05	0.000142	CcSEcCtD
Sitaxentan—Hypotension—Valproic Acid—epilepsy syndrome	2.98e-05	0.000142	CcSEcCtD
Sitaxentan—Asthenia—Carbamazepine—epilepsy syndrome	2.98e-05	0.000142	CcSEcCtD
Sitaxentan—Agitation—Gabapentin—epilepsy syndrome	2.98e-05	0.000142	CcSEcCtD
Sitaxentan—Diarrhoea—Phenytoin—epilepsy syndrome	2.98e-05	0.000142	CcSEcCtD
Sitaxentan—Discomfort—Pregabalin—epilepsy syndrome	2.97e-05	0.000142	CcSEcCtD
Sitaxentan—Nausea—Fosphenytoin—epilepsy syndrome	2.97e-05	0.000142	CcSEcCtD
Sitaxentan—Diarrhoea—Oxcarbazepine—epilepsy syndrome	2.96e-05	0.000141	CcSEcCtD
Sitaxentan—Hypersensitivity—Lamotrigine—epilepsy syndrome	2.96e-05	0.000141	CcSEcCtD
Sitaxentan—Vomiting—Felbamate—epilepsy syndrome	2.95e-05	0.000141	CcSEcCtD
Sitaxentan—Dry mouth—Pregabalin—epilepsy syndrome	2.94e-05	0.00014	CcSEcCtD
Sitaxentan—Rash—Felbamate—epilepsy syndrome	2.93e-05	0.00014	CcSEcCtD
Sitaxentan—Eye disorder—Topiramate—epilepsy syndrome	2.93e-05	0.000139	CcSEcCtD
Sitaxentan—Dermatitis—Felbamate—epilepsy syndrome	2.93e-05	0.000139	CcSEcCtD
Sitaxentan—Malaise—Gabapentin—epilepsy syndrome	2.92e-05	0.000139	CcSEcCtD
Sitaxentan—Tinnitus—Topiramate—epilepsy syndrome	2.92e-05	0.000139	CcSEcCtD
Sitaxentan—Vertigo—Gabapentin—epilepsy syndrome	2.91e-05	0.000139	CcSEcCtD
Sitaxentan—Headache—Felbamate—epilepsy syndrome	2.91e-05	0.000139	CcSEcCtD
Sitaxentan—Confusional state—Pregabalin—epilepsy syndrome	2.91e-05	0.000139	CcSEcCtD
Sitaxentan—Cardiac disorder—Topiramate—epilepsy syndrome	2.91e-05	0.000139	CcSEcCtD
Sitaxentan—Flushing—Topiramate—epilepsy syndrome	2.91e-05	0.000139	CcSEcCtD
Sitaxentan—Leukopenia—Gabapentin—epilepsy syndrome	2.9e-05	0.000138	CcSEcCtD
Sitaxentan—Dizziness—Clonazepam—epilepsy syndrome	2.9e-05	0.000138	CcSEcCtD
Sitaxentan—Nausea—Vigabatrin—epilepsy syndrome	2.9e-05	0.000138	CcSEcCtD
Sitaxentan—Vomiting—Zonisamide—epilepsy syndrome	2.89e-05	0.000138	CcSEcCtD
Sitaxentan—Insomnia—Valproic Acid—epilepsy syndrome	2.89e-05	0.000137	CcSEcCtD
Sitaxentan—Oedema—Pregabalin—epilepsy syndrome	2.89e-05	0.000137	CcSEcCtD
Sitaxentan—Asthenia—Lamotrigine—epilepsy syndrome	2.88e-05	0.000137	CcSEcCtD
Sitaxentan—Dizziness—Phenytoin—epilepsy syndrome	2.88e-05	0.000137	CcSEcCtD
Sitaxentan—Rash—Zonisamide—epilepsy syndrome	2.87e-05	0.000137	CcSEcCtD
Sitaxentan—Infection—Pregabalin—epilepsy syndrome	2.87e-05	0.000137	CcSEcCtD
Sitaxentan—Dermatitis—Zonisamide—epilepsy syndrome	2.87e-05	0.000136	CcSEcCtD
Sitaxentan—Dizziness—Oxcarbazepine—epilepsy syndrome	2.86e-05	0.000136	CcSEcCtD
Sitaxentan—Nausea—Diazepam—epilepsy syndrome	2.85e-05	0.000136	CcSEcCtD
Sitaxentan—Headache—Zonisamide—epilepsy syndrome	2.85e-05	0.000136	CcSEcCtD
Sitaxentan—Diarrhoea—Carbamazepine—epilepsy syndrome	2.84e-05	0.000135	CcSEcCtD
Sitaxentan—Angiopathy—Topiramate—epilepsy syndrome	2.84e-05	0.000135	CcSEcCtD
Sitaxentan—Somnolence—Valproic Acid—epilepsy syndrome	2.84e-05	0.000135	CcSEcCtD
Sitaxentan—Immune system disorder—Topiramate—epilepsy syndrome	2.83e-05	0.000135	CcSEcCtD
Sitaxentan—Nervous system disorder—Pregabalin—epilepsy syndrome	2.83e-05	0.000135	CcSEcCtD
Sitaxentan—Thrombocytopenia—Pregabalin—epilepsy syndrome	2.83e-05	0.000135	CcSEcCtD
Sitaxentan—Mediastinal disorder—Topiramate—epilepsy syndrome	2.82e-05	0.000134	CcSEcCtD
Sitaxentan—Tachycardia—Pregabalin—epilepsy syndrome	2.82e-05	0.000134	CcSEcCtD
Sitaxentan—Dyspepsia—Valproic Acid—epilepsy syndrome	2.81e-05	0.000134	CcSEcCtD
Sitaxentan—Skin disorder—Pregabalin—epilepsy syndrome	2.8e-05	0.000133	CcSEcCtD
Sitaxentan—Vomiting—Clonazepam—epilepsy syndrome	2.79e-05	0.000133	CcSEcCtD
Sitaxentan—Decreased appetite—Valproic Acid—epilepsy syndrome	2.77e-05	0.000132	CcSEcCtD
Sitaxentan—Alopecia—Topiramate—epilepsy syndrome	2.77e-05	0.000132	CcSEcCtD
Sitaxentan—Vomiting—Phenytoin—epilepsy syndrome	2.77e-05	0.000132	CcSEcCtD
Sitaxentan—Rash—Clonazepam—epilepsy syndrome	2.76e-05	0.000132	CcSEcCtD
Sitaxentan—Dermatitis—Clonazepam—epilepsy syndrome	2.76e-05	0.000132	CcSEcCtD
Sitaxentan—Chest pain—Gabapentin—epilepsy syndrome	2.76e-05	0.000131	CcSEcCtD
Sitaxentan—Nausea—Felbamate—epilepsy syndrome	2.76e-05	0.000131	CcSEcCtD
Sitaxentan—Gastrointestinal disorder—Valproic Acid—epilepsy syndrome	2.76e-05	0.000131	CcSEcCtD
Sitaxentan—Vomiting—Oxcarbazepine—epilepsy syndrome	2.75e-05	0.000131	CcSEcCtD
Sitaxentan—Fatigue—Valproic Acid—epilepsy syndrome	2.75e-05	0.000131	CcSEcCtD
Sitaxentan—Anorexia—Pregabalin—epilepsy syndrome	2.75e-05	0.000131	CcSEcCtD
Sitaxentan—Dizziness—Carbamazepine—epilepsy syndrome	2.75e-05	0.000131	CcSEcCtD
Sitaxentan—Diarrhoea—Lamotrigine—epilepsy syndrome	2.75e-05	0.000131	CcSEcCtD
Sitaxentan—Headache—Clonazepam—epilepsy syndrome	2.75e-05	0.000131	CcSEcCtD
Sitaxentan—Rash—Phenytoin—epilepsy syndrome	2.75e-05	0.000131	CcSEcCtD
Sitaxentan—Mental disorder—Topiramate—epilepsy syndrome	2.75e-05	0.000131	CcSEcCtD
Sitaxentan—Dermatitis—Phenytoin—epilepsy syndrome	2.74e-05	0.000131	CcSEcCtD
Sitaxentan—Unspecified disorder of skin and subcutaneous tissue—Gabapentin—epilepsy syndrome	2.74e-05	0.000131	CcSEcCtD
Sitaxentan—Rash—Oxcarbazepine—epilepsy syndrome	2.73e-05	0.00013	CcSEcCtD
Sitaxentan—Pain—Valproic Acid—epilepsy syndrome	2.73e-05	0.00013	CcSEcCtD
Sitaxentan—Constipation—Valproic Acid—epilepsy syndrome	2.73e-05	0.00013	CcSEcCtD
Sitaxentan—Dermatitis—Oxcarbazepine—epilepsy syndrome	2.73e-05	0.00013	CcSEcCtD
Sitaxentan—Headache—Phenytoin—epilepsy syndrome	2.73e-05	0.00013	CcSEcCtD
Sitaxentan—Malnutrition—Topiramate—epilepsy syndrome	2.73e-05	0.00013	CcSEcCtD
Sitaxentan—Discomfort—Gabapentin—epilepsy syndrome	2.73e-05	0.00013	CcSEcCtD
Sitaxentan—Headache—Oxcarbazepine—epilepsy syndrome	2.71e-05	0.000129	CcSEcCtD
Sitaxentan—Nausea—Zonisamide—epilepsy syndrome	2.7e-05	0.000129	CcSEcCtD
Sitaxentan—Dry mouth—Gabapentin—epilepsy syndrome	2.7e-05	0.000129	CcSEcCtD
Sitaxentan—Hypotension—Pregabalin—epilepsy syndrome	2.7e-05	0.000128	CcSEcCtD
Sitaxentan—Tension—Topiramate—epilepsy syndrome	2.68e-05	0.000127	CcSEcCtD
Sitaxentan—Confusional state—Gabapentin—epilepsy syndrome	2.67e-05	0.000127	CcSEcCtD
Sitaxentan—Dizziness—Lamotrigine—epilepsy syndrome	2.66e-05	0.000127	CcSEcCtD
Sitaxentan—Nervousness—Topiramate—epilepsy syndrome	2.65e-05	0.000126	CcSEcCtD
Sitaxentan—Oedema—Gabapentin—epilepsy syndrome	2.65e-05	0.000126	CcSEcCtD
Sitaxentan—Vomiting—Carbamazepine—epilepsy syndrome	2.64e-05	0.000126	CcSEcCtD
Sitaxentan—Feeling abnormal—Valproic Acid—epilepsy syndrome	2.63e-05	0.000125	CcSEcCtD
Sitaxentan—Infection—Gabapentin—epilepsy syndrome	2.63e-05	0.000125	CcSEcCtD
Sitaxentan—Muscle spasms—Topiramate—epilepsy syndrome	2.62e-05	0.000125	CcSEcCtD
Sitaxentan—Rash—Carbamazepine—epilepsy syndrome	2.62e-05	0.000125	CcSEcCtD
Sitaxentan—Dermatitis—Carbamazepine—epilepsy syndrome	2.62e-05	0.000125	CcSEcCtD
Sitaxentan—Insomnia—Pregabalin—epilepsy syndrome	2.61e-05	0.000124	CcSEcCtD
Sitaxentan—Nausea—Clonazepam—epilepsy syndrome	2.6e-05	0.000124	CcSEcCtD
Sitaxentan—Headache—Carbamazepine—epilepsy syndrome	2.6e-05	0.000124	CcSEcCtD
Sitaxentan—Nervous system disorder—Gabapentin—epilepsy syndrome	2.59e-05	0.000124	CcSEcCtD
Sitaxentan—Thrombocytopenia—Gabapentin—epilepsy syndrome	2.59e-05	0.000123	CcSEcCtD
Sitaxentan—Nausea—Phenytoin—epilepsy syndrome	2.59e-05	0.000123	CcSEcCtD
Sitaxentan—Tachycardia—Gabapentin—epilepsy syndrome	2.58e-05	0.000123	CcSEcCtD
Sitaxentan—Nausea—Oxcarbazepine—epilepsy syndrome	2.57e-05	0.000123	CcSEcCtD
Sitaxentan—Skin disorder—Gabapentin—epilepsy syndrome	2.57e-05	0.000122	CcSEcCtD
Sitaxentan—Somnolence—Pregabalin—epilepsy syndrome	2.57e-05	0.000122	CcSEcCtD
Sitaxentan—Tremor—Topiramate—epilepsy syndrome	2.56e-05	0.000122	CcSEcCtD
Sitaxentan—Vomiting—Lamotrigine—epilepsy syndrome	2.55e-05	0.000122	CcSEcCtD
Sitaxentan—Urticaria—Valproic Acid—epilepsy syndrome	2.54e-05	0.000121	CcSEcCtD
Sitaxentan—Rash—Lamotrigine—epilepsy syndrome	2.53e-05	0.000121	CcSEcCtD
Sitaxentan—Ill-defined disorder—Topiramate—epilepsy syndrome	2.53e-05	0.000121	CcSEcCtD
Sitaxentan—Dermatitis—Lamotrigine—epilepsy syndrome	2.53e-05	0.000121	CcSEcCtD
Sitaxentan—Body temperature increased—Valproic Acid—epilepsy syndrome	2.52e-05	0.00012	CcSEcCtD
Sitaxentan—Anorexia—Gabapentin—epilepsy syndrome	2.52e-05	0.00012	CcSEcCtD
Sitaxentan—Anaemia—Topiramate—epilepsy syndrome	2.52e-05	0.00012	CcSEcCtD
Sitaxentan—Headache—Lamotrigine—epilepsy syndrome	2.52e-05	0.00012	CcSEcCtD
Sitaxentan—Decreased appetite—Pregabalin—epilepsy syndrome	2.51e-05	0.000119	CcSEcCtD
Sitaxentan—Agitation—Topiramate—epilepsy syndrome	2.51e-05	0.000119	CcSEcCtD
Sitaxentan—Gastrointestinal disorder—Pregabalin—epilepsy syndrome	2.49e-05	0.000119	CcSEcCtD
Sitaxentan—Fatigue—Pregabalin—epilepsy syndrome	2.49e-05	0.000118	CcSEcCtD
Sitaxentan—Hypotension—Gabapentin—epilepsy syndrome	2.47e-05	0.000118	CcSEcCtD
Sitaxentan—Nausea—Carbamazepine—epilepsy syndrome	2.47e-05	0.000118	CcSEcCtD
Sitaxentan—Pain—Pregabalin—epilepsy syndrome	2.47e-05	0.000118	CcSEcCtD
Sitaxentan—Constipation—Pregabalin—epilepsy syndrome	2.47e-05	0.000118	CcSEcCtD
Sitaxentan—Malaise—Topiramate—epilepsy syndrome	2.46e-05	0.000117	CcSEcCtD
Sitaxentan—Vertigo—Topiramate—epilepsy syndrome	2.45e-05	0.000117	CcSEcCtD
Sitaxentan—Leukopenia—Topiramate—epilepsy syndrome	2.44e-05	0.000116	CcSEcCtD
Sitaxentan—Insomnia—Gabapentin—epilepsy syndrome	2.39e-05	0.000114	CcSEcCtD
Sitaxentan—Nausea—Lamotrigine—epilepsy syndrome	2.39e-05	0.000114	CcSEcCtD
Sitaxentan—Feeling abnormal—Pregabalin—epilepsy syndrome	2.38e-05	0.000113	CcSEcCtD
Sitaxentan—Somnolence—Gabapentin—epilepsy syndrome	2.35e-05	0.000112	CcSEcCtD
Sitaxentan—Hypersensitivity—Valproic Acid—epilepsy syndrome	2.35e-05	0.000112	CcSEcCtD
Sitaxentan—Dyspepsia—Gabapentin—epilepsy syndrome	2.33e-05	0.000111	CcSEcCtD
Sitaxentan—Chest pain—Topiramate—epilepsy syndrome	2.32e-05	0.000111	CcSEcCtD
Sitaxentan—Unspecified disorder of skin and subcutaneous tissue—Topiramate—epilepsy syndrome	2.31e-05	0.00011	CcSEcCtD
Sitaxentan—Decreased appetite—Gabapentin—epilepsy syndrome	2.3e-05	0.00011	CcSEcCtD
Sitaxentan—Discomfort—Topiramate—epilepsy syndrome	2.29e-05	0.000109	CcSEcCtD
Sitaxentan—Urticaria—Pregabalin—epilepsy syndrome	2.29e-05	0.000109	CcSEcCtD
Sitaxentan—Asthenia—Valproic Acid—epilepsy syndrome	2.29e-05	0.000109	CcSEcCtD
Sitaxentan—Gastrointestinal disorder—Gabapentin—epilepsy syndrome	2.28e-05	0.000109	CcSEcCtD
Sitaxentan—Fatigue—Gabapentin—epilepsy syndrome	2.28e-05	0.000109	CcSEcCtD
Sitaxentan—Body temperature increased—Pregabalin—epilepsy syndrome	2.28e-05	0.000109	CcSEcCtD
Sitaxentan—Dry mouth—Topiramate—epilepsy syndrome	2.27e-05	0.000108	CcSEcCtD
Sitaxentan—Constipation—Gabapentin—epilepsy syndrome	2.26e-05	0.000108	CcSEcCtD
Sitaxentan—Pain—Gabapentin—epilepsy syndrome	2.26e-05	0.000108	CcSEcCtD
Sitaxentan—Confusional state—Topiramate—epilepsy syndrome	2.24e-05	0.000107	CcSEcCtD
Sitaxentan—Oedema—Topiramate—epilepsy syndrome	2.23e-05	0.000106	CcSEcCtD
Sitaxentan—Infection—Topiramate—epilepsy syndrome	2.21e-05	0.000105	CcSEcCtD
Sitaxentan—Diarrhoea—Valproic Acid—epilepsy syndrome	2.18e-05	0.000104	CcSEcCtD
Sitaxentan—Nervous system disorder—Topiramate—epilepsy syndrome	2.18e-05	0.000104	CcSEcCtD
Sitaxentan—Feeling abnormal—Gabapentin—epilepsy syndrome	2.18e-05	0.000104	CcSEcCtD
Sitaxentan—Thrombocytopenia—Topiramate—epilepsy syndrome	2.18e-05	0.000104	CcSEcCtD
Sitaxentan—Tachycardia—Topiramate—epilepsy syndrome	2.17e-05	0.000103	CcSEcCtD
Sitaxentan—Skin disorder—Topiramate—epilepsy syndrome	2.16e-05	0.000103	CcSEcCtD
Sitaxentan—Hypersensitivity—Pregabalin—epilepsy syndrome	2.13e-05	0.000101	CcSEcCtD
Sitaxentan—Anorexia—Topiramate—epilepsy syndrome	2.12e-05	0.000101	CcSEcCtD
Sitaxentan—Dizziness—Valproic Acid—epilepsy syndrome	2.11e-05	0.000101	CcSEcCtD
Sitaxentan—Urticaria—Gabapentin—epilepsy syndrome	2.1e-05	0.0001	CcSEcCtD
Sitaxentan—Body temperature increased—Gabapentin—epilepsy syndrome	2.09e-05	9.96e-05	CcSEcCtD
Sitaxentan—Hypotension—Topiramate—epilepsy syndrome	2.08e-05	9.91e-05	CcSEcCtD
Sitaxentan—Asthenia—Pregabalin—epilepsy syndrome	2.07e-05	9.86e-05	CcSEcCtD
Sitaxentan—Vomiting—Valproic Acid—epilepsy syndrome	2.03e-05	9.67e-05	CcSEcCtD
Sitaxentan—Insomnia—Topiramate—epilepsy syndrome	2.01e-05	9.59e-05	CcSEcCtD
Sitaxentan—Rash—Valproic Acid—epilepsy syndrome	2.01e-05	9.59e-05	CcSEcCtD
Sitaxentan—Dermatitis—Valproic Acid—epilepsy syndrome	2.01e-05	9.58e-05	CcSEcCtD
Sitaxentan—Headache—Valproic Acid—epilepsy syndrome	2e-05	9.52e-05	CcSEcCtD
Sitaxentan—Somnolence—Topiramate—epilepsy syndrome	1.98e-05	9.43e-05	CcSEcCtD
Sitaxentan—Diarrhoea—Pregabalin—epilepsy syndrome	1.97e-05	9.4e-05	CcSEcCtD
Sitaxentan—Dyspepsia—Topiramate—epilepsy syndrome	1.96e-05	9.33e-05	CcSEcCtD
Sitaxentan—Hypersensitivity—Gabapentin—epilepsy syndrome	1.95e-05	9.28e-05	CcSEcCtD
Sitaxentan—Decreased appetite—Topiramate—epilepsy syndrome	1.94e-05	9.22e-05	CcSEcCtD
Sitaxentan—Gastrointestinal disorder—Topiramate—epilepsy syndrome	1.92e-05	9.15e-05	CcSEcCtD
Sitaxentan—Fatigue—Topiramate—epilepsy syndrome	1.92e-05	9.14e-05	CcSEcCtD
Sitaxentan—Dizziness—Pregabalin—epilepsy syndrome	1.91e-05	9.09e-05	CcSEcCtD
Sitaxentan—Constipation—Topiramate—epilepsy syndrome	1.9e-05	9.07e-05	CcSEcCtD
Sitaxentan—Pain—Topiramate—epilepsy syndrome	1.9e-05	9.07e-05	CcSEcCtD
Sitaxentan—Asthenia—Gabapentin—epilepsy syndrome	1.9e-05	9.04e-05	CcSEcCtD
Sitaxentan—Nausea—Valproic Acid—epilepsy syndrome	1.9e-05	9.03e-05	CcSEcCtD
Sitaxentan—Vomiting—Pregabalin—epilepsy syndrome	1.83e-05	8.74e-05	CcSEcCtD
Sitaxentan—Feeling abnormal—Topiramate—epilepsy syndrome	1.83e-05	8.74e-05	CcSEcCtD
Sitaxentan—Rash—Pregabalin—epilepsy syndrome	1.82e-05	8.67e-05	CcSEcCtD
Sitaxentan—Dermatitis—Pregabalin—epilepsy syndrome	1.82e-05	8.66e-05	CcSEcCtD
Sitaxentan—Diarrhoea—Gabapentin—epilepsy syndrome	1.81e-05	8.62e-05	CcSEcCtD
Sitaxentan—Headache—Pregabalin—epilepsy syndrome	1.81e-05	8.61e-05	CcSEcCtD
Sitaxentan—Urticaria—Topiramate—epilepsy syndrome	1.77e-05	8.42e-05	CcSEcCtD
Sitaxentan—Body temperature increased—Topiramate—epilepsy syndrome	1.76e-05	8.38e-05	CcSEcCtD
Sitaxentan—Dizziness—Gabapentin—epilepsy syndrome	1.75e-05	8.33e-05	CcSEcCtD
Sitaxentan—Nausea—Pregabalin—epilepsy syndrome	1.71e-05	8.16e-05	CcSEcCtD
Sitaxentan—Vomiting—Gabapentin—epilepsy syndrome	1.68e-05	8.01e-05	CcSEcCtD
Sitaxentan—Rash—Gabapentin—epilepsy syndrome	1.67e-05	7.95e-05	CcSEcCtD
Sitaxentan—Dermatitis—Gabapentin—epilepsy syndrome	1.67e-05	7.94e-05	CcSEcCtD
Sitaxentan—Headache—Gabapentin—epilepsy syndrome	1.66e-05	7.89e-05	CcSEcCtD
Sitaxentan—Hypersensitivity—Topiramate—epilepsy syndrome	1.64e-05	7.81e-05	CcSEcCtD
Sitaxentan—Asthenia—Topiramate—epilepsy syndrome	1.6e-05	7.61e-05	CcSEcCtD
Sitaxentan—EDNRB—Signaling Pathways—YWHAZ—epilepsy syndrome	1.59e-05	0.000161	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling by GPCR—PRKCB—epilepsy syndrome	1.59e-05	0.000161	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling by GPCR—IL6ST—epilepsy syndrome	1.58e-05	0.00016	CbGpPWpGaD
Sitaxentan—Nausea—Gabapentin—epilepsy syndrome	1.57e-05	7.49e-05	CcSEcCtD
Sitaxentan—EDNRB—Signaling Pathways—NGF—epilepsy syndrome	1.57e-05	0.000159	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—JUNB—epilepsy syndrome	1.56e-05	0.000159	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—CNR1—epilepsy syndrome	1.56e-05	0.000159	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—PLCB1—epilepsy syndrome	1.56e-05	0.000158	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—CCR5—epilepsy syndrome	1.53e-05	0.000155	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—HTR7—epilepsy syndrome	1.53e-05	0.000155	CbGpPWpGaD
Sitaxentan—Diarrhoea—Topiramate—epilepsy syndrome	1.52e-05	7.25e-05	CcSEcCtD
Sitaxentan—CYP2C19—Metabolism—GAMT—epilepsy syndrome	1.52e-05	0.000154	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—NHLRC1—epilepsy syndrome	1.52e-05	0.000154	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—EPM2A—epilepsy syndrome	1.52e-05	0.000154	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—PNPO—epilepsy syndrome	1.52e-05	0.000154	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—PDXK—epilepsy syndrome	1.51e-05	0.000154	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—L2HGDH—epilepsy syndrome	1.51e-05	0.000154	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—ADK—epilepsy syndrome	1.51e-05	0.000154	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—FAR1—epilepsy syndrome	1.51e-05	0.000154	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—GLUD1—epilepsy syndrome	1.51e-05	0.000154	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—CERS1—epilepsy syndrome	1.51e-05	0.000154	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—HTR2A—epilepsy syndrome	1.49e-05	0.000152	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—HBEGF—epilepsy syndrome	1.48e-05	0.00015	CbGpPWpGaD
Sitaxentan—Dizziness—Topiramate—epilepsy syndrome	1.47e-05	7.01e-05	CcSEcCtD
Sitaxentan—EDNRA—Signaling Pathways—AKT3—epilepsy syndrome	1.45e-05	0.000148	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling by GPCR—POMC—epilepsy syndrome	1.44e-05	0.000147	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—ADAM10—epilepsy syndrome	1.42e-05	0.000144	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—TSC2—epilepsy syndrome	1.42e-05	0.000144	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—AGT—epilepsy syndrome	1.42e-05	0.000144	CbGpPWpGaD
Sitaxentan—Vomiting—Topiramate—epilepsy syndrome	1.42e-05	6.74e-05	CcSEcCtD
Sitaxentan—EDNRA—Signaling by GPCR—CCL2—epilepsy syndrome	1.41e-05	0.000144	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—CA4—epilepsy syndrome	1.41e-05	0.000143	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—QDPR—epilepsy syndrome	1.41e-05	0.000143	CbGpPWpGaD
Sitaxentan—CYP2C19—Biological oxidations—POMC—epilepsy syndrome	1.41e-05	0.000143	CbGpPWpGaD
Sitaxentan—Rash—Topiramate—epilepsy syndrome	1.4e-05	6.69e-05	CcSEcCtD
Sitaxentan—Dermatitis—Topiramate—epilepsy syndrome	1.4e-05	6.68e-05	CcSEcCtD
Sitaxentan—Headache—Topiramate—epilepsy syndrome	1.39e-05	6.64e-05	CcSEcCtD
Sitaxentan—EDNRB—Signaling Pathways—APOE—epilepsy syndrome	1.39e-05	0.000141	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—PNPO—epilepsy syndrome	1.39e-05	0.000141	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—GAMT—epilepsy syndrome	1.39e-05	0.000141	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—EPM2A—epilepsy syndrome	1.39e-05	0.000141	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—NHLRC1—epilepsy syndrome	1.39e-05	0.000141	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—KDR—epilepsy syndrome	1.36e-05	0.000138	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—S100B—epilepsy syndrome	1.34e-05	0.000136	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—SOCS3—epilepsy syndrome	1.33e-05	0.000135	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—COX3—epilepsy syndrome	1.33e-05	0.000135	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—CDC42—epilepsy syndrome	1.33e-05	0.000135	CbGpPWpGaD
Sitaxentan—Nausea—Topiramate—epilepsy syndrome	1.32e-05	6.3e-05	CcSEcCtD
Sitaxentan—CYP3A4—Metabolism—CA13—epilepsy syndrome	1.32e-05	0.000134	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—PRKCB—epilepsy syndrome	1.31e-05	0.000133	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—IL6ST—epilepsy syndrome	1.3e-05	0.000132	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—CA4—epilepsy syndrome	1.29e-05	0.000131	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—QDPR—epilepsy syndrome	1.29e-05	0.000131	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—AVP—epilepsy syndrome	1.28e-05	0.00013	CbGpPWpGaD
Sitaxentan—CYP2C9—Biological oxidations—POMC—epilepsy syndrome	1.28e-05	0.00013	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—PFKL—epilepsy syndrome	1.26e-05	0.000128	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—SLCO1A2—epilepsy syndrome	1.26e-05	0.000128	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—CACNA2D2—epilepsy syndrome	1.26e-05	0.000128	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—KCNB1—epilepsy syndrome	1.26e-05	0.000128	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—SLC6A8—epilepsy syndrome	1.26e-05	0.000128	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism of lipids and lipoproteins—CYP11A1—epilepsy syndrome	1.22e-05	0.000124	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—HES1—epilepsy syndrome	1.21e-05	0.000123	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—COX3—epilepsy syndrome	1.21e-05	0.000123	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—POMC—epilepsy syndrome	1.19e-05	0.000121	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—FYN—epilepsy syndrome	1.18e-05	0.00012	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—H2AFX—epilepsy syndrome	1.18e-05	0.00012	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—MEF2C—epilepsy syndrome	1.17e-05	0.000119	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—CCL2—epilepsy syndrome	1.17e-05	0.000119	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—UPB1—epilepsy syndrome	1.15e-05	0.000117	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—ATIC—epilepsy syndrome	1.15e-05	0.000117	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—NEU1—epilepsy syndrome	1.15e-05	0.000117	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—KCNB1—epilepsy syndrome	1.15e-05	0.000117	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—CACNA2D2—epilepsy syndrome	1.15e-05	0.000117	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—PFKL—epilepsy syndrome	1.15e-05	0.000117	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—SLCO1A2—epilepsy syndrome	1.15e-05	0.000117	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—SLC6A8—epilepsy syndrome	1.15e-05	0.000117	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—YWHAZ—epilepsy syndrome	1.14e-05	0.000115	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—NGF—epilepsy syndrome	1.12e-05	0.000114	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism of lipids and lipoproteins—CYP2C19—epilepsy syndrome	1.12e-05	0.000114	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism of lipids and lipoproteins—CYP11A1—epilepsy syndrome	1.11e-05	0.000113	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—HSD17B4—epilepsy syndrome	1.11e-05	0.000113	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—CCR5—epilepsy syndrome	1.09e-05	0.000111	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—GBE1—epilepsy syndrome	1.07e-05	0.000109	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—PPP1R3C—epilepsy syndrome	1.07e-05	0.000109	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—HTR2A—epilepsy syndrome	1.07e-05	0.000109	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—FGF2—epilepsy syndrome	1.05e-05	0.000107	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—ATIC—epilepsy syndrome	1.05e-05	0.000107	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—UPB1—epilepsy syndrome	1.05e-05	0.000107	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—NEU1—epilepsy syndrome	1.05e-05	0.000107	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism of lipids and lipoproteins—BCHE—epilepsy syndrome	1.05e-05	0.000106	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—TSC2—epilepsy syndrome	1.01e-05	0.000103	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—AGT—epilepsy syndrome	1.01e-05	0.000103	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—HSD17B4—epilepsy syndrome	1.01e-05	0.000103	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—ASAH1—epilepsy syndrome	1.01e-05	0.000102	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—ADK—epilepsy syndrome	9.99e-06	0.000101	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—FAR1—epilepsy syndrome	9.99e-06	0.000101	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—GLUD1—epilepsy syndrome	9.99e-06	0.000101	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—L2HGDH—epilepsy syndrome	9.99e-06	0.000101	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—PDXK—epilepsy syndrome	9.99e-06	0.000101	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—CERS1—epilepsy syndrome	9.99e-06	0.000101	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—APOE—epilepsy syndrome	9.93e-06	0.000101	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—STXBP1—epilepsy syndrome	9.79e-06	9.94e-05	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—RELA—epilepsy syndrome	9.79e-06	9.94e-05	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—PPP1R3C—epilepsy syndrome	9.76e-06	9.91e-05	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—GBE1—epilepsy syndrome	9.76e-06	9.91e-05	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—KDR—epilepsy syndrome	9.73e-06	9.89e-05	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—MTOR—epilepsy syndrome	9.6e-06	9.75e-05	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—NT5E—epilepsy syndrome	9.54e-06	9.69e-05	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—ALAD—epilepsy syndrome	9.54e-06	9.69e-05	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism of lipids and lipoproteins—BCHE—epilepsy syndrome	9.54e-06	9.69e-05	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—PRKCB—epilepsy syndrome	9.37e-06	9.52e-05	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—IL6ST—epilepsy syndrome	9.33e-06	9.48e-05	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—ASAH1—epilepsy syndrome	9.18e-06	9.32e-05	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—EPM2A—epilepsy syndrome	9.14e-06	9.28e-05	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—GAMT—epilepsy syndrome	9.14e-06	9.28e-05	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—NHLRC1—epilepsy syndrome	9.14e-06	9.28e-05	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—PNPO—epilepsy syndrome	9.14e-06	9.28e-05	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—ALDH7A1—epilepsy syndrome	9.1e-06	9.25e-05	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—CACNA1A—epilepsy syndrome	9.1e-06	9.25e-05	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—STXBP1—epilepsy syndrome	8.93e-06	9.07e-05	CbGpPWpGaD
Sitaxentan—EDNRB—GPCR downstream signaling—AKT1—epilepsy syndrome	8.91e-06	9.05e-05	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—ST3GAL3—epilepsy syndrome	8.91e-06	9.05e-05	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—CASP3—epilepsy syndrome	8.83e-06	8.97e-05	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—ADSL—epilepsy syndrome	8.73e-06	8.86e-05	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—NT5E—epilepsy syndrome	8.7e-06	8.84e-05	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—ALAD—epilepsy syndrome	8.7e-06	8.84e-05	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—JUN—epilepsy syndrome	8.57e-06	8.71e-05	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—GLUL—epilepsy syndrome	8.56e-06	8.69e-05	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—POMC—epilepsy syndrome	8.53e-06	8.67e-05	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—CA4—epilepsy syndrome	8.49e-06	8.63e-05	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—QDPR—epilepsy syndrome	8.49e-06	8.63e-05	CbGpPWpGaD
Sitaxentan—CYP3A4—Biological oxidations—POMC—epilepsy syndrome	8.47e-06	8.6e-05	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—CACNA1D—epilepsy syndrome	8.4e-06	8.53e-05	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—CCL2—epilepsy syndrome	8.35e-06	8.48e-05	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—MMP9—epilepsy syndrome	8.34e-06	8.47e-05	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—CACNA1A—epilepsy syndrome	8.3e-06	8.43e-05	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—ALDH7A1—epilepsy syndrome	8.3e-06	8.43e-05	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—ST3GAL3—epilepsy syndrome	8.12e-06	8.25e-05	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling by GPCR—AKT1—epilepsy syndrome	8.09e-06	8.22e-05	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—COX3—epilepsy syndrome	7.99e-06	8.11e-05	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—ADSL—epilepsy syndrome	7.96e-06	8.08e-05	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—TXNRD1—epilepsy syndrome	7.86e-06	7.98e-05	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—GLUL—epilepsy syndrome	7.8e-06	7.93e-05	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—SRC—epilepsy syndrome	7.69e-06	7.81e-05	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—CACNA1D—epilepsy syndrome	7.66e-06	7.78e-05	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—AQP1—epilepsy syndrome	7.63e-06	7.75e-05	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—PFKL—epilepsy syndrome	7.57e-06	7.69e-05	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—SLCO1A2—epilepsy syndrome	7.57e-06	7.69e-05	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—KCNB1—epilepsy syndrome	7.57e-06	7.69e-05	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—CACNA2D2—epilepsy syndrome	7.57e-06	7.69e-05	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—SLC6A8—epilepsy syndrome	7.57e-06	7.69e-05	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—FGF2—epilepsy syndrome	7.55e-06	7.66e-05	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—VEGFA—epilepsy syndrome	7.49e-06	7.61e-05	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism of lipids and lipoproteins—GPX1—epilepsy syndrome	7.33e-06	7.44e-05	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—TXNRD1—epilepsy syndrome	7.16e-06	7.28e-05	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—RELA—epilepsy syndrome	7e-06	7.12e-05	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—AQP1—epilepsy syndrome	6.95e-06	7.06e-05	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—UPB1—epilepsy syndrome	6.92e-06	7.03e-05	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—NEU1—epilepsy syndrome	6.92e-06	7.03e-05	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—ATIC—epilepsy syndrome	6.92e-06	7.03e-05	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—CHRM3—epilepsy syndrome	6.9e-06	7.01e-05	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—KCNJ11—epilepsy syndrome	6.9e-06	7.01e-05	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—MTOR—epilepsy syndrome	6.87e-06	6.98e-05	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—epilepsy syndrome	6.68e-06	6.79e-05	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—HSD17B4—epilepsy syndrome	6.66e-06	6.77e-05	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—PPP1R3C—epilepsy syndrome	6.44e-06	6.54e-05	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—GBE1—epilepsy syndrome	6.44e-06	6.54e-05	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	6.42e-06	6.52e-05	CbGpPWpGaD
Sitaxentan—EDNRA—GPCR downstream signaling—AKT1—epilepsy syndrome	6.38e-06	6.48e-05	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—CASP3—epilepsy syndrome	6.32e-06	6.42e-05	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	6.29e-06	6.39e-05	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—CHRM3—epilepsy syndrome	6.29e-06	6.39e-05	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—KCNJ11—epilepsy syndrome	6.29e-06	6.39e-05	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—JUN—epilepsy syndrome	6.14e-06	6.23e-05	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—ASAH1—epilepsy syndrome	6.05e-06	6.15e-05	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—MMP9—epilepsy syndrome	5.97e-06	6.06e-05	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—STXBP1—epilepsy syndrome	5.89e-06	5.98e-05	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	5.86e-06	5.95e-05	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling by GPCR—AKT1—epilepsy syndrome	5.79e-06	5.88e-05	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	5.74e-06	5.83e-05	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—NT5E—epilepsy syndrome	5.74e-06	5.83e-05	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—ALAD—epilepsy syndrome	5.74e-06	5.83e-05	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—ABCG2—epilepsy syndrome	5.62e-06	5.71e-05	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—SRC—epilepsy syndrome	5.5e-06	5.59e-05	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—CACNA1A—epilepsy syndrome	5.47e-06	5.56e-05	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—ALDH7A1—epilepsy syndrome	5.47e-06	5.56e-05	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—CYP11A1—epilepsy syndrome	5.45e-06	5.53e-05	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	5.41e-06	5.49e-05	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—VEGFA—epilepsy syndrome	5.36e-06	5.45e-05	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—ST3GAL3—epilepsy syndrome	5.36e-06	5.44e-05	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—ADSL—epilepsy syndrome	5.25e-06	5.33e-05	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—GLUL—epilepsy syndrome	5.15e-06	5.23e-05	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—ABCG2—epilepsy syndrome	5.13e-06	5.21e-05	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—CACNA1D—epilepsy syndrome	5.05e-06	5.13e-05	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—CYP2C19—epilepsy syndrome	5e-06	5.08e-05	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—CYP11A1—epilepsy syndrome	4.97e-06	5.04e-05	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	4.93e-06	5.01e-05	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	4.93e-06	5.01e-05	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—CYP2D6—epilepsy syndrome	4.91e-06	4.99e-05	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—AKT1—epilepsy syndrome	4.78e-06	4.86e-05	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—TXNRD1—epilepsy syndrome	4.72e-06	4.8e-05	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—ADRA2A—epilepsy syndrome	4.68e-06	4.75e-05	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—BCHE—epilepsy syndrome	4.66e-06	4.73e-05	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—AQP1—epilepsy syndrome	4.59e-06	4.66e-05	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	4.49e-06	4.57e-05	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—CYP2D6—epilepsy syndrome	4.48e-06	4.55e-05	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—SLC2A1—epilepsy syndrome	4.44e-06	4.52e-05	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—PLCB1—epilepsy syndrome	4.4e-06	4.47e-05	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—TH—epilepsy syndrome	4.38e-06	4.45e-05	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	4.31e-06	4.38e-05	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—ADRA2A—epilepsy syndrome	4.27e-06	4.33e-05	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—BCHE—epilepsy syndrome	4.25e-06	4.32e-05	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—KCNJ11—epilepsy syndrome	4.15e-06	4.21e-05	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—CHRM3—epilepsy syndrome	4.15e-06	4.21e-05	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—SLC2A1—epilepsy syndrome	4.05e-06	4.12e-05	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—PLCB1—epilepsy syndrome	4.01e-06	4.07e-05	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—TH—epilepsy syndrome	3.99e-06	4.06e-05	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	3.93e-06	3.99e-05	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—HMOX1—epilepsy syndrome	3.66e-06	3.71e-05	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—CAT—epilepsy syndrome	3.61e-06	3.66e-05	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—ABCB1—epilepsy syndrome	3.51e-06	3.56e-05	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—AKT1—epilepsy syndrome	3.42e-06	3.47e-05	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—ABCG2—epilepsy syndrome	3.38e-06	3.43e-05	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—HMOX1—epilepsy syndrome	3.33e-06	3.39e-05	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—CYP2C19—epilepsy syndrome	3.3e-06	3.35e-05	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—CAT—epilepsy syndrome	3.29e-06	3.34e-05	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—CYP11A1—epilepsy syndrome	3.27e-06	3.33e-05	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—GPX1—epilepsy syndrome	3.26e-06	3.31e-05	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—ABCB1—epilepsy syndrome	3.2e-06	3.25e-05	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—GPX1—epilepsy syndrome	2.97e-06	3.02e-05	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—CYP2D6—epilepsy syndrome	2.96e-06	3e-05	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—AGT—epilepsy syndrome	2.86e-06	2.91e-05	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—ADRA2A—epilepsy syndrome	2.81e-06	2.86e-05	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—APOE—epilepsy syndrome	2.8e-06	2.85e-05	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—BCHE—epilepsy syndrome	2.8e-06	2.85e-05	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—SLC2A1—epilepsy syndrome	2.67e-06	2.72e-05	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—PLCB1—epilepsy syndrome	2.64e-06	2.69e-05	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—TH—epilepsy syndrome	2.63e-06	2.68e-05	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—AGT—epilepsy syndrome	2.61e-06	2.65e-05	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—APOE—epilepsy syndrome	2.56e-06	2.6e-05	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—POMC—epilepsy syndrome	2.41e-06	2.45e-05	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—HMOX1—epilepsy syndrome	2.2e-06	2.23e-05	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—POMC—epilepsy syndrome	2.2e-06	2.23e-05	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—ALB—epilepsy syndrome	2.2e-06	2.23e-05	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—CAT—epilepsy syndrome	2.17e-06	2.2e-05	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—ABCB1—epilepsy syndrome	2.11e-06	2.14e-05	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—ALB—epilepsy syndrome	2e-06	2.03e-05	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—GPX1—epilepsy syndrome	1.96e-06	1.99e-05	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—PTGS2—epilepsy syndrome	1.92e-06	1.95e-05	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—PTGS2—epilepsy syndrome	1.75e-06	1.78e-05	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—AGT—epilepsy syndrome	1.72e-06	1.75e-05	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—APOE—epilepsy syndrome	1.69e-06	1.71e-05	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—POMC—epilepsy syndrome	1.45e-06	1.47e-05	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—ALB—epilepsy syndrome	1.32e-06	1.34e-05	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—PTGS2—epilepsy syndrome	1.15e-06	1.17e-05	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—AKT1—epilepsy syndrome	9.65e-07	9.81e-06	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—AKT1—epilepsy syndrome	8.8e-07	8.94e-06	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—AKT1—epilepsy syndrome	5.8e-07	5.9e-06	CbGpPWpGaD
